Fundz

Coriolis Pharma Appoints Dr. Teun Van Der Heide as Chief Executive Officer

Nov 04, 2026
New to company · from ten23 health“His career includes senior positions at Lonza, where he headed the business units Bioscience Solutions and Capsule Delivery Solutions (Capsugel), and most recently at ten23 health, where he served as Chief Business Officer (CBO)”

Position

Chief Executive Officer

Company

Coriolis Pharma

Teun van der Heide
BavariaBiotechnology

Description

Coriolis Pharma announced the appointment of Dr. Teun van der Heide as Chief Executive Officer (CEO), effective November 2, 2026. He brings extensive leadership and commercial experience in the pharmaceutical and life sciences industries.

Who to call at Coriolis Pharma, and when

A new leader at Coriolis Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Coriolis Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Coriolis Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Coriolis Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Coriolis Pharma

Location

Bavaria, Germany

About

Coriolis Pharma is a globally operating contract research and development organization (CRDO) specializing in drug product development, analytical services, and manufacturing services for biological therapeutics. Combining scientific excellence with innovative technologies, including AI-powered in silico modeling, Coriolis helps accelerate and de-risk drug development from early development through market approval. Headquartered in Martinsried near Munich, Germany, with a growing U.S. presence anchored by its headquarters and laboratory in North Carolina.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Coriolis Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Coriolis Pharma's next move

Learn about Strategic plan

Coriolis Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.